nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—systemic scleroderma	0.25	0.418	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Captopril—systemic scleroderma	0.106	0.177	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—systemic scleroderma	0.0823	0.138	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—systemic scleroderma	0.0784	0.131	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—systemic scleroderma	0.0479	0.0802	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—systemic scleroderma	0.0334	0.0559	CbGbCtD
Dinoprost Tromethamine—PTGIR—pulmonary artery—systemic scleroderma	0.0214	0.148	CbGeAlD
Dinoprost Tromethamine—TBXA2R—artery—systemic scleroderma	0.0146	0.101	CbGeAlD
Dinoprost Tromethamine—TBXA2R—endothelium—systemic scleroderma	0.0124	0.0854	CbGeAlD
Dinoprost Tromethamine—TBXA2R—blood vessel—systemic scleroderma	0.0114	0.0788	CbGeAlD
Dinoprost Tromethamine—PTGIR—artery—systemic scleroderma	0.00794	0.0549	CbGeAlD
Dinoprost Tromethamine—PTGIR—endothelium—systemic scleroderma	0.00671	0.0463	CbGeAlD
Dinoprost Tromethamine—PTGIR—blood vessel—systemic scleroderma	0.00619	0.0427	CbGeAlD
Dinoprost Tromethamine—PTGER3—connective tissue—systemic scleroderma	0.0045	0.0311	CbGeAlD
Dinoprost Tromethamine—PTGER3—smooth muscle tissue—systemic scleroderma	0.00412	0.0284	CbGeAlD
Dinoprost Tromethamine—HPGDS—connective tissue—systemic scleroderma	0.00389	0.0269	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lung—systemic scleroderma	0.00353	0.0244	CbGeAlD
Dinoprost Tromethamine—PTGFR—smooth muscle tissue—systemic scleroderma	0.00329	0.0227	CbGeAlD
Dinoprost Tromethamine—PTGER3—digestive system—systemic scleroderma	0.00325	0.0225	CbGeAlD
Dinoprost Tromethamine—PTGIR—connective tissue—systemic scleroderma	0.00317	0.0219	CbGeAlD
Dinoprost Tromethamine—PTGIR—smooth muscle tissue—systemic scleroderma	0.0029	0.02	CbGeAlD
Dinoprost Tromethamine—HPGDS—digestive system—systemic scleroderma	0.00281	0.0194	CbGeAlD
Dinoprost Tromethamine—PTGER3—lung—systemic scleroderma	0.00272	0.0188	CbGeAlD
Dinoprost Tromethamine—HPGDS—tendon—systemic scleroderma	0.00268	0.0185	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—skin of body—systemic scleroderma	0.0025	0.0173	CbGeAlD
Dinoprost Tromethamine—PTGFR—tendon—systemic scleroderma	0.00247	0.0171	CbGeAlD
Dinoprost Tromethamine—HPGDS—lung—systemic scleroderma	0.00235	0.0162	CbGeAlD
Dinoprost Tromethamine—PTGIR—digestive system—systemic scleroderma	0.00229	0.0158	CbGeAlD
Dinoprost Tromethamine—SLC22A11—digestive system—systemic scleroderma	0.00223	0.0154	CbGeAlD
Dinoprost Tromethamine—SLC22A7—digestive system—systemic scleroderma	0.00218	0.0151	CbGeAlD
Dinoprost Tromethamine—PTGFR—lung—systemic scleroderma	0.00217	0.015	CbGeAlD
Dinoprost Tromethamine—SLC22A2—digestive system—systemic scleroderma	0.00194	0.0134	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—tendon—systemic scleroderma	0.00192	0.0133	CbGeAlD
Dinoprost Tromethamine—PTGIR—lung—systemic scleroderma	0.00191	0.0132	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—tendon—systemic scleroderma	0.00191	0.0132	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lung—systemic scleroderma	0.00169	0.0117	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lung—systemic scleroderma	0.00167	0.0116	CbGeAlD
Dinoprost Tromethamine—TBXA2R—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.000751	0.0482	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—G alpha (12/13) signalling events—RHOB—systemic scleroderma	0.00075	0.0482	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000719	0.0462	CbGpPWpGaD
Dinoprost Tromethamine—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000594	0.00245	CcSEcCtD
Dinoprost Tromethamine—Malaise—Leflunomide—systemic scleroderma	0.00059	0.00243	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Lisinopril—systemic scleroderma	0.000585	0.00241	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000584	0.00241	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Mometasone—systemic scleroderma	0.000583	0.0024	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Mometasone—systemic scleroderma	0.000583	0.0024	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Azathioprine—systemic scleroderma	0.000582	0.0024	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Captopril—systemic scleroderma	0.000581	0.0024	CcSEcCtD
Dinoprost Tromethamine—Chills—Lisinopril—systemic scleroderma	0.000579	0.00239	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000579	0.00239	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Captopril—systemic scleroderma	0.000577	0.00238	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000576	0.00237	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Captopril—systemic scleroderma	0.000576	0.00237	CcSEcCtD
Dinoprost Tromethamine—Agitation—Mycophenolic acid—systemic scleroderma	0.000573	0.00236	CcSEcCtD
Dinoprost Tromethamine—Cough—Leflunomide—systemic scleroderma	0.00057	0.00235	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Pentoxifylline—systemic scleroderma	0.000565	0.00233	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000565	0.0363	CbGpPWpGaD
Dinoprost Tromethamine—Hypertension—Leflunomide—systemic scleroderma	0.000564	0.00233	CcSEcCtD
Dinoprost Tromethamine—Malaise—Mycophenolic acid—systemic scleroderma	0.000562	0.00232	CcSEcCtD
Dinoprost Tromethamine—Infection—Azathioprine—systemic scleroderma	0.000561	0.00231	CcSEcCtD
Dinoprost Tromethamine—Syncope—Mycophenolic acid—systemic scleroderma	0.000559	0.00231	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Leflunomide—systemic scleroderma	0.000557	0.0023	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Methotrexate—systemic scleroderma	0.000553	0.00228	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Leflunomide—systemic scleroderma	0.00055	0.00227	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000548	0.00226	CcSEcCtD
Dinoprost Tromethamine—Cough—Mycophenolic acid—systemic scleroderma	0.000544	0.00224	CcSEcCtD
Dinoprost Tromethamine—Back pain—Lisinopril—systemic scleroderma	0.000543	0.00224	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Pentoxifylline—systemic scleroderma	0.000543	0.00224	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00054	0.00223	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Lisinopril—systemic scleroderma	0.00054	0.00223	CcSEcCtD
Dinoprost Tromethamine—Rash—Pentoxifylline—systemic scleroderma	0.000539	0.00222	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000538	0.00222	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000538	0.00222	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000538	0.0345	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Pentoxifylline—systemic scleroderma	0.000535	0.00221	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000535	0.00221	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Captopril—systemic scleroderma	0.000533	0.0022	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000532	0.0022	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000531	0.00219	CcSEcCtD
Dinoprost Tromethamine—Infection—Leflunomide—systemic scleroderma	0.00053	0.00219	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000529	0.00218	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Mometasone—systemic scleroderma	0.000529	0.00218	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Azathioprine—systemic scleroderma	0.000528	0.00218	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Prednisone—systemic scleroderma	0.000527	0.00217	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000526	0.0338	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000526	0.0338	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000525	0.00216	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Mometasone—systemic scleroderma	0.000521	0.00215	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000521	0.00215	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Leflunomide—systemic scleroderma	0.000521	0.00215	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000516	0.00213	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00212	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Captopril—systemic scleroderma	0.000512	0.00211	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Captopril—systemic scleroderma	0.000512	0.00211	CcSEcCtD
Dinoprost Tromethamine—Nausea—Pentoxifylline—systemic scleroderma	0.000507	0.00209	CcSEcCtD
Dinoprost Tromethamine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00209	CcSEcCtD
Dinoprost Tromethamine—Malaise—Lisinopril—systemic scleroderma	0.000507	0.00209	CcSEcCtD
Dinoprost Tromethamine—Infection—Mycophenolic acid—systemic scleroderma	0.000506	0.00209	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Mometasone—systemic scleroderma	0.000504	0.00208	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Prednisone—systemic scleroderma	0.000504	0.00208	CcSEcCtD
Dinoprost Tromethamine—Syncope—Lisinopril—systemic scleroderma	0.000504	0.00208	CcSEcCtD
Dinoprost Tromethamine—Shock—Mycophenolic acid—systemic scleroderma	0.000501	0.00207	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Leflunomide—systemic scleroderma	0.000499	0.00206	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000497	0.00205	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.000496	0.0318	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000494	0.00204	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000492	0.00203	CcSEcCtD
Dinoprost Tromethamine—Cough—Lisinopril—systemic scleroderma	0.00049	0.00202	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Endothelin Pathways—EDN1—systemic scleroderma	0.000488	0.0313	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Leflunomide—systemic scleroderma	0.000479	0.00198	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Lisinopril—systemic scleroderma	0.000478	0.00197	CcSEcCtD
Dinoprost Tromethamine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000476	0.00196	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Leflunomide—systemic scleroderma	0.000476	0.00196	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000476	0.00196	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000473	0.00195	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Lisinopril—systemic scleroderma	0.000473	0.00195	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Mometasone—systemic scleroderma	0.000469	0.00193	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000466	0.00192	CcSEcCtD
Dinoprost Tromethamine—Rash—Mometasone—systemic scleroderma	0.000465	0.00192	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Captopril—systemic scleroderma	0.000464	0.00192	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mometasone—systemic scleroderma	0.000464	0.00191	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000462	0.00191	CcSEcCtD
Dinoprost Tromethamine—Headache—Mometasone—systemic scleroderma	0.000462	0.0019	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Captopril—systemic scleroderma	0.000458	0.00189	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000457	0.00188	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000457	0.00188	CcSEcCtD
Dinoprost Tromethamine—Pain—Leflunomide—systemic scleroderma	0.000456	0.00188	CcSEcCtD
Dinoprost Tromethamine—Infection—Lisinopril—systemic scleroderma	0.000455	0.00188	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000454	0.00187	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000452	0.00187	CcSEcCtD
Dinoprost Tromethamine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00187	CcSEcCtD
Dinoprost Tromethamine—Shock—Lisinopril—systemic scleroderma	0.000451	0.00186	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Lisinopril—systemic scleroderma	0.000447	0.00185	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Azathioprine—systemic scleroderma	0.000447	0.00184	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Azathioprine—systemic scleroderma	0.000447	0.00184	CcSEcCtD
Dinoprost Tromethamine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00183	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000443	0.00183	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Captopril—systemic scleroderma	0.000443	0.00183	CcSEcCtD
Dinoprost Tromethamine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000441	0.00182	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00044	0.00181	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mometasone—systemic scleroderma	0.000438	0.00181	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000436	0.0018	CcSEcCtD
Dinoprost Tromethamine—Pain—Mycophenolic acid—systemic scleroderma	0.000435	0.00179	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00178	CcSEcCtD
Dinoprost Tromethamine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00177	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Lisinopril—systemic scleroderma	0.000428	0.00177	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Captopril—systemic scleroderma	0.000428	0.00177	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00176	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00175	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Leflunomide—systemic scleroderma	0.000422	0.00174	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Leflunomide—systemic scleroderma	0.000422	0.00174	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000419	0.00173	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00173	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000416	0.00172	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000416	0.00172	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00171	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Lisinopril—systemic scleroderma	0.000412	0.0017	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Captopril—systemic scleroderma	0.000412	0.0017	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Lisinopril—systemic scleroderma	0.000409	0.00169	CcSEcCtD
Dinoprost Tromethamine—Rash—Captopril—systemic scleroderma	0.000408	0.00168	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Captopril—systemic scleroderma	0.000408	0.00168	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Lisinopril—systemic scleroderma	0.000408	0.00168	CcSEcCtD
Dinoprost Tromethamine—Headache—Captopril—systemic scleroderma	0.000406	0.00167	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000402	0.00166	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000402	0.00166	CcSEcCtD
Dinoprost Tromethamine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000399	0.00165	CcSEcCtD
Dinoprost Tromethamine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000395	0.00163	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000393	0.00162	CcSEcCtD
Dinoprost Tromethamine—Pain—Lisinopril—systemic scleroderma	0.000392	0.00162	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000392	0.00162	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Prednisone—systemic scleroderma	0.00039	0.00161	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000388	0.0016	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Azathioprine—systemic scleroderma	0.000387	0.00159	CcSEcCtD
Dinoprost Tromethamine—Nausea—Captopril—systemic scleroderma	0.000385	0.00159	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Leflunomide—systemic scleroderma	0.000383	0.00158	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000378	0.00156	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Leflunomide—systemic scleroderma	0.000377	0.00156	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00155	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000375	0.00155	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—systemic scleroderma	0.000374	0.00154	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Azathioprine—systemic scleroderma	0.000374	0.00154	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000365	0.00151	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Leflunomide—systemic scleroderma	0.000365	0.00151	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Lisinopril—systemic scleroderma	0.000362	0.00149	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Lisinopril—systemic scleroderma	0.000362	0.00149	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00149	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00036	0.00149	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Azathioprine—systemic scleroderma	0.000359	0.00148	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000358	0.00148	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000357	0.00147	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—systemic scleroderma	0.000357	0.00147	CcSEcCtD
Dinoprost Tromethamine—Rash—Azathioprine—systemic scleroderma	0.000356	0.00147	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Azathioprine—systemic scleroderma	0.000356	0.00147	CcSEcCtD
Dinoprost Tromethamine—Headache—Azathioprine—systemic scleroderma	0.000354	0.00146	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Leflunomide—systemic scleroderma	0.000353	0.00145	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000348	0.00144	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Prednisone—systemic scleroderma	0.000348	0.00143	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Prednisone—systemic scleroderma	0.000346	0.00143	CcSEcCtD
Dinoprost Tromethamine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00142	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—systemic scleroderma	0.000342	0.00141	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—systemic scleroderma	0.00034	0.0014	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Leflunomide—systemic scleroderma	0.000339	0.0014	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000338	0.0217	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000338	0.00139	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000337	0.00139	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—systemic scleroderma	0.000337	0.00139	CcSEcCtD
Dinoprost Tromethamine—Rash—Leflunomide—systemic scleroderma	0.000336	0.00139	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Leflunomide—systemic scleroderma	0.000336	0.00139	CcSEcCtD
Dinoprost Tromethamine—Nausea—Azathioprine—systemic scleroderma	0.000336	0.00138	CcSEcCtD
Dinoprost Tromethamine—Headache—Leflunomide—systemic scleroderma	0.000334	0.00138	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000331	0.00137	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Lisinopril—systemic scleroderma	0.000329	0.00136	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00135	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Lisinopril—systemic scleroderma	0.000324	0.00134	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000324	0.00133	CcSEcCtD
Dinoprost Tromethamine—Rash—Mycophenolic acid—systemic scleroderma	0.000321	0.00132	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000321	0.00132	CcSEcCtD
Dinoprost Tromethamine—Headache—Mycophenolic acid—systemic scleroderma	0.000319	0.00131	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00131	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00131	CcSEcCtD
Dinoprost Tromethamine—Nausea—Leflunomide—systemic scleroderma	0.000317	0.00131	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000316	0.0203	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Lisinopril—systemic scleroderma	0.000314	0.00129	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Prednisone—systemic scleroderma	0.00031	0.00128	CcSEcCtD
Dinoprost Tromethamine—Agitation—Prednisone—systemic scleroderma	0.000307	0.00126	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Lisinopril—systemic scleroderma	0.000303	0.00125	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mycophenolic acid—systemic scleroderma	0.000302	0.00125	CcSEcCtD
Dinoprost Tromethamine—Malaise—Prednisone—systemic scleroderma	0.000301	0.00124	CcSEcCtD
Dinoprost Tromethamine—Syncope—Prednisone—systemic scleroderma	0.000299	0.00123	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Endothelin Pathways—NOS3—systemic scleroderma	0.000297	0.0191	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00122	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Thromboxane A2 receptor signaling—NOS3—systemic scleroderma	0.000295	0.0189	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Prednisone—systemic scleroderma	0.000293	0.00121	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Lisinopril—systemic scleroderma	0.000291	0.0012	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—systemic scleroderma	0.000291	0.0012	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Dinoprost Tromethamine—Rash—Lisinopril—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Prednisone—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Lisinopril—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00119	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Prednisone—systemic scleroderma	0.000288	0.00119	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000288	0.0185	CbGpPWpGaD
Dinoprost Tromethamine—Chills—Methotrexate—systemic scleroderma	0.000287	0.00119	CcSEcCtD
Dinoprost Tromethamine—Headache—Lisinopril—systemic scleroderma	0.000287	0.00118	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00117	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Prednisone—systemic scleroderma	0.000281	0.00116	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00113	CcSEcCtD
Dinoprost Tromethamine—Nausea—Lisinopril—systemic scleroderma	0.000272	0.00112	CcSEcCtD
Dinoprost Tromethamine—Infection—Prednisone—systemic scleroderma	0.000271	0.00112	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—systemic scleroderma	0.00027	0.00111	CcSEcCtD
Dinoprost Tromethamine—Shock—Prednisone—systemic scleroderma	0.000268	0.0011	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Prednisone—systemic scleroderma	0.000266	0.0011	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000266	0.0011	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000263	0.00109	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000259	0.00107	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00105	CcSEcCtD
Dinoprost Tromethamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00104	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00104	CcSEcCtD
Dinoprost Tromethamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00104	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—systemic scleroderma	0.000251	0.00104	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Prednisone—systemic scleroderma	0.000244	0.00101	CcSEcCtD
Dinoprost Tromethamine—Cough—Methotrexate—systemic scleroderma	0.000243	0.001	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—systemic scleroderma	0.000242	0.000996	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000984	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—systemic scleroderma	0.000237	0.000979	CcSEcCtD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—EDN1—systemic scleroderma	0.000235	0.0151	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Methotrexate—systemic scleroderma	0.000235	0.000967	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—systemic scleroderma	0.000226	0.000932	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Prednisone—systemic scleroderma	0.000224	0.000925	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000223	0.000918	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00022	0.000907	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Prednisone—systemic scleroderma	0.000215	0.000888	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Prednisone—systemic scleroderma	0.000215	0.000888	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—systemic scleroderma	0.000213	0.000877	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—systemic scleroderma	0.000204	0.000843	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—systemic scleroderma	0.000203	0.000837	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—systemic scleroderma	0.000202	0.000834	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000201	0.000827	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Prednisone—systemic scleroderma	0.000195	0.000806	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Thromboxane A2 receptor signaling—NOS3—systemic scleroderma	0.000195	0.0125	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Methotrexate—systemic scleroderma	0.000195	0.000802	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Prednisone—systemic scleroderma	0.000193	0.000794	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000188	0.000773	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Prednisone—systemic scleroderma	0.000186	0.000768	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000186	0.000767	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—G alpha (q) signalling events—EDN1—systemic scleroderma	0.000184	0.0118	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Prednisone—systemic scleroderma	0.00018	0.000743	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—systemic scleroderma	0.00018	0.000742	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—systemic scleroderma	0.00018	0.000742	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SELP—systemic scleroderma	0.000174	0.0112	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Prednisone—systemic scleroderma	0.000173	0.000714	CcSEcCtD
Dinoprost Tromethamine—Rash—Prednisone—systemic scleroderma	0.000172	0.000708	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisone—systemic scleroderma	0.000172	0.000707	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisone—systemic scleroderma	0.000171	0.000703	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000168	0.000691	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.000165	0.0106	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Methotrexate—systemic scleroderma	0.000163	0.000673	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—RHOB—systemic scleroderma	0.000163	0.0105	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Prednisone—systemic scleroderma	0.000162	0.000667	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—systemic scleroderma	0.000161	0.000664	CcSEcCtD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—CCL2—systemic scleroderma	0.000161	0.0103	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000157	0.0101	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—systemic scleroderma	0.000156	0.000642	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000153	0.00984	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Methotrexate—systemic scleroderma	0.00015	0.000621	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Platelet homeostasis—NOS3—systemic scleroderma	0.000149	0.00958	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—CSK—systemic scleroderma	0.000148	0.00952	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Methotrexate—systemic scleroderma	0.000145	0.000597	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—systemic scleroderma	0.000143	0.000592	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—systemic scleroderma	0.000143	0.000591	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—systemic scleroderma	0.000143	0.000588	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—ITGAM—systemic scleroderma	0.000139	0.00895	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Methotrexate—systemic scleroderma	0.000135	0.000557	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—RHOB—systemic scleroderma	0.000133	0.00852	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—G alpha (q) signalling events—EDN1—systemic scleroderma	0.000124	0.00798	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000122	0.00784	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—G alpha (q) signalling events—EDN1—systemic scleroderma	0.000122	0.00782	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—RHOB—systemic scleroderma	0.000121	0.00774	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—EDN1—systemic scleroderma	0.00012	0.0077	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000116	0.00746	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SELP—systemic scleroderma	0.000115	0.00739	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.000111	0.00714	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.00011	0.00707	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.000109	0.00699	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000108	0.00691	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—RHOB—systemic scleroderma	0.000108	0.0069	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—RHOB—systemic scleroderma	0.000103	0.00661	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—CSK—systemic scleroderma	9.79e-05	0.00629	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—RHOB—systemic scleroderma	9.35e-05	0.006	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—EDN1—systemic scleroderma	9.3e-05	0.00597	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—RHOB—systemic scleroderma	9.28e-05	0.00596	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—ITGAM—systemic scleroderma	9.21e-05	0.00591	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SMAD7—systemic scleroderma	9.21e-05	0.00591	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—RHOB—systemic scleroderma	8.43e-05	0.00541	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—EDN1—systemic scleroderma	8.39e-05	0.00538	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	8.35e-05	0.00536	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	8.24e-05	0.00529	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—CCL2—systemic scleroderma	8.2e-05	0.00526	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	8.06e-05	0.00518	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	8.06e-05	0.00518	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	8.01e-05	0.00514	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	7.53e-05	0.00483	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SMAD7—systemic scleroderma	7.14e-05	0.00458	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RHOB—systemic scleroderma	7.12e-05	0.00457	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—MMP1—systemic scleroderma	6.99e-05	0.00449	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—RHOB—systemic scleroderma	6.94e-05	0.00446	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—HSPG2—systemic scleroderma	6.83e-05	0.00438	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—RHOB—systemic scleroderma	6.8e-05	0.00436	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—RHOB—systemic scleroderma	6.8e-05	0.00436	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—EDN1—systemic scleroderma	6.78e-05	0.00435	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HSPG2—systemic scleroderma	6.72e-05	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	6.5e-05	0.00417	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CSK—systemic scleroderma	6.49e-05	0.00416	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SMAD7—systemic scleroderma	6.44e-05	0.00413	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CCL2—systemic scleroderma	6.36e-05	0.00408	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—RHOB—systemic scleroderma	6.3e-05	0.00405	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—EDN1—systemic scleroderma	6.27e-05	0.00403	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—RHOB—systemic scleroderma	6.17e-05	0.00396	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—RHOB—systemic scleroderma	6.17e-05	0.00396	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EDN1—systemic scleroderma	6.15e-05	0.00395	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—EDN1—systemic scleroderma	6.14e-05	0.00394	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—EDN1—systemic scleroderma	6.14e-05	0.00394	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CCL2—systemic scleroderma	5.73e-05	0.00368	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	5.63e-05	0.00361	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RHOB—systemic scleroderma	5.52e-05	0.00354	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	5.51e-05	0.00354	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	5.51e-05	0.00354	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—EDN1—systemic scleroderma	5.26e-05	0.00337	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HSPG2—systemic scleroderma	5.21e-05	0.00334	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CTGF—systemic scleroderma	5.18e-05	0.00332	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—NOS3—systemic scleroderma	5.07e-05	0.00325	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CSK—systemic scleroderma	5.03e-05	0.00323	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RHOB—systemic scleroderma	4.98e-05	0.0032	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SMAD7—systemic scleroderma	4.81e-05	0.00309	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EDN1—systemic scleroderma	4.77e-05	0.00306	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—EDN1—systemic scleroderma	4.74e-05	0.00304	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SMAD7—systemic scleroderma	4.71e-05	0.00303	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SMAD7—systemic scleroderma	4.71e-05	0.00303	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HSPG2—systemic scleroderma	4.7e-05	0.00302	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—MMP1—systemic scleroderma	4.61e-05	0.00296	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CSK—systemic scleroderma	4.54e-05	0.00291	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EDN1—systemic scleroderma	4.3e-05	0.00276	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCL2—systemic scleroderma	4.29e-05	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCL2—systemic scleroderma	4.21e-05	0.0027	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCL2—systemic scleroderma	4.2e-05	0.00269	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCL2—systemic scleroderma	4.2e-05	0.00269	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RHOB—systemic scleroderma	3.72e-05	0.00239	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RHOB—systemic scleroderma	3.65e-05	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RHOB—systemic scleroderma	3.65e-05	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EDN1—systemic scleroderma	3.64e-05	0.00233	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—EDN1—systemic scleroderma	3.54e-05	0.00228	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HSPG2—systemic scleroderma	3.51e-05	0.00225	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—EDN1—systemic scleroderma	3.47e-05	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—EDN1—systemic scleroderma	3.47e-05	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HSPG2—systemic scleroderma	3.44e-05	0.00221	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HSPG2—systemic scleroderma	3.44e-05	0.00221	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CSK—systemic scleroderma	3.39e-05	0.00218	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TGFB1—systemic scleroderma	3.35e-05	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NOS3—systemic scleroderma	3.34e-05	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CSK—systemic scleroderma	3.32e-05	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CSK—systemic scleroderma	3.32e-05	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL2—systemic scleroderma	3.26e-05	0.00209	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EDN1—systemic scleroderma	3.22e-05	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EDN1—systemic scleroderma	3.15e-05	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EDN1—systemic scleroderma	3.15e-05	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL2—systemic scleroderma	2.94e-05	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EDN1—systemic scleroderma	2.82e-05	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EDN1—systemic scleroderma	2.54e-05	0.00163	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL2—systemic scleroderma	2.49e-05	0.0016	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—NOS3—systemic scleroderma	2.25e-05	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOS3—systemic scleroderma	2.22e-05	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TGFB1—systemic scleroderma	2.21e-05	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—systemic scleroderma	2.2e-05	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL2—systemic scleroderma	2.15e-05	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—systemic scleroderma	2.15e-05	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL2—systemic scleroderma	1.93e-05	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EDN1—systemic scleroderma	1.9e-05	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EDN1—systemic scleroderma	1.86e-05	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EDN1—systemic scleroderma	1.86e-05	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HSPG2—systemic scleroderma	1.78e-05	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—systemic scleroderma	1.78e-05	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL2—systemic scleroderma	1.74e-05	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOS3—systemic scleroderma	1.72e-05	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOS3—systemic scleroderma	1.55e-05	0.000995	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFB1—systemic scleroderma	1.46e-05	0.00094	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—systemic scleroderma	1.38e-05	0.000885	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CTGF—systemic scleroderma	1.35e-05	0.000865	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL2—systemic scleroderma	1.3e-05	0.000834	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL2—systemic scleroderma	1.27e-05	0.000817	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL2—systemic scleroderma	1.27e-05	0.000817	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—systemic scleroderma	1.24e-05	0.000798	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOS3—systemic scleroderma	1.16e-05	0.000744	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFB1—systemic scleroderma	1.14e-05	0.000729	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOS3—systemic scleroderma	1.13e-05	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOS3—systemic scleroderma	1.13e-05	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFB1—systemic scleroderma	1.02e-05	0.000658	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—systemic scleroderma	9.29e-06	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—systemic scleroderma	9.1e-06	0.000584	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—systemic scleroderma	9.1e-06	0.000584	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—systemic scleroderma	7.66e-06	0.000492	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFB1—systemic scleroderma	7.5e-06	0.000481	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—systemic scleroderma	7.5e-06	0.000481	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NOS3—systemic scleroderma	5.87e-06	0.000377	CbGpPWpGaD
